BioSpace News Archive

DalCor Pharmaceuticals announced the appointment of Diane E. Sullivan as Chief Commercial Officer effective June 1, 2020.

Applied Therapeutics, Inc. announced that three abstracts have been selected, including one oral presentation, at the upcoming American Diabetes Association’s 80th Scientific Sessions: A Virtual Experience taking place June 12-16, 2020.

Constellation Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel therapeutics, today announced that Jeffrey Humphrey, M.D., will join Constellation Pharmaceuticals as Chief Medical Officer. Dr. Humphrey is a medical oncologist with over twenty years’ experience in drug development. Most recently he was Chief Development Officer at Kyowa Kirin Co., where he over